Zydus Lifesciences Limited received final approval from the US Food and Drug Administration (USFDA) to manufacture Ketoconazole Shampoo, 2 per cent, according to the announcement issued by the ...
The stock of Zydus Lifesciences has been in a steady decline since August last year after facing resistance at ₹1,300. After witnessing some consolidation between ₹940 and ₹1,000 in December ...
The board approved the demerger of the consumer products division of Cadila Healthcare into Carnation, which is a subsidiary of Cadila Healthcare and the merger of Zydus Hospital and Medical ...
THE GOOD KARMA HOSPITAL tells the story of junior doctor, Ruby Walker, who arrives in India looking for a job and a distraction from her heartbreak. She anticipates the sunshine, the palm trees ...
Nippon India Small Cap Fund - Direct (IDCW) 467.76 29,95,942 0.92 Nippon India Small Cap Fund - Direct (G) 467.76 29,95,942 0.92 Nippon India Small Cap Fund - Direct ...
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Zydus Lifesciences Ltd. is a Public Limited Listed company incorporated on 15/05/1995 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is ...
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Zydus Lifesciences launches ANVIMO, a breakthrough drug for preventing Cytomegalovirus infection in transplant patients, offering a safer and more affordable treatment option. Mar 05, 2025 15:16 Zydus ...
*Ministry of Corporate Affairs, 2019, Company/LLP Data, (Government of India administrative body to govern and regulate corporate affairs through the Companies Act ...
Zydus Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 ,inter alia, to consider and approve unaudited financial results of the ...